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Low density lipoprotein  (LDL) 1 is a  major class of plasma lipoprotein,  the metab- 
olism  and  biological  interactions  of which  are  of particular  interest  in  view of the 
association between elevated levels and the incidence of coronary heart disease (1, 2). 
There is much evidence implicating abnormal deposition of LDL in arterial  walls in 
the pathogenesis of atherosclerosis, although the molecular mechanisms of this depo- 
sition  are  not  well  understood  (3,  4).  LDL  is  derived  by  metabolism  of very  low 
density lipoproteins (VLDL), and both these classes of lipoprotein particles, as well as 
high density lipoprotein  (HDL), consist of apoproteins together with varying propor- 
tions of phospholipid, triglyceride, esterified, and nonesterified cholesterol  (5). 
C-reactive protein  (CRP)  is a  plasma protein the concentration of which increases 
from normal values of<l  mg/liter to as much as several hundred mg/liter in response 
to most forms of tissue injury, inflammation, or infection (6, 7). It is known to bind in 
vitro to phospholipids in the form ofliposomes (8) or in modified cell membranes (9), 
and  CRP  may be  deposited  on  damaged  or  necrotic  cells  in  vivo  (10-12).  These 
reactions  involve  two  binding  sites  in  the  CRP  molecule,  one,  which  is  calcium- 
dependent,  binds phosphorylcholine residues  (13-15),  whereas  the other binds poly- 
cations (16). However, CRP does not bind to the intact membranes of normal healthy 
cells  either  in  vivo  or  in  vitro,  and  in  experiments  with  phosphatidyl  choline/ 
cholesterol  liposomes,  in vitro inclusion of a  proportion  of lysophosphatidyl choline 
has been found necessary to promote significant binding by CRP (8, 9). 
The in vivo function of CRP is not known, though it is presumably both important 
and generally beneficial to the organism because proteins that closely resemble human 
CRP both in structure and in their calcium-dependent capacity to bind phosphoryl- 
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choline  have  been  stably  conserved  throughout  vertebrate  evolution  (17,  18). A 
homologous phosphorylcholine-binding protein has even been recognized recently in 
an invertebrate, Limulus polyphemus, the horseshoe crab (19,  20). 
There are reports (21-25) in the earlier literature of association between CRP and 
serum  lipoproteins during isolation of CRP,  but  estimates of the molecular size of 
CRP in human or rabbit serum did not suggest that CRP is complexed to a significant 
extent within  the circulation  (26).  Interactions under other circumstances between 
CRP and plasma constituents containing phospholipids or other potential ligands for 
CRP have not previously been investigated. We have reexamined the molecular form 
of CRP in acute phase serum and confirmed that it exists in the free state and is not 
complexed with macromolecular ligand(s). However, we report here for the first time 
that  when  isolated  CRP  is  aggregated  on  a  solid  phase  at  a  sufficient  density,  it 
acquires the capacity to selectively bind LDL and traces of VLDL from whole human 
serum. This interaction, occurring only after aggregation of CRP molecules has taken 
place,  may  have  important  implications  both  for  the  function  of CRP  and  the 
clearance and metabolism of LDL. 
Materials and Methods 
Proteins.  CRP was isolated in pure form as described elsewhere (27, 28).  Briefly, CRP was 
obtained by calcium-dependent affinity chromatography on a column of Sepharose-cyanogen 
bromide  (CNBr)-pneumococcal C-polysaccharide and  then  gel  filtered on  Uhrogel  AcA44 
(LKB Instruments, Ltd., London, England) in the presence of calcium ions. To ensure removal 
of any trace contaminants, the CRP was passed over a column of Sepharose to which polyvalent 
anti-normal human  serum  (NHS)  antibodies were  coupled and  was  finally gel  filtered on 
Sephacryl $300  (Pharmacia  [G.B.]  Ltd.,  Hounslow,  Middlesex, England).  The  final  CRP 
preparations contained a  single component  by gradient  polyacrylamide gel electrophoresis 
(PAGE)  of the  undenatured  protein  and  by  sodium  dodecyl  sulphate  (SDS)-PAGE.  No 
contaminants  were  detectable by  immunoelectrophoresis or crossed  immunoelectrophoresis 
against antiserum to NHS, and prolonged immunization with the CRP yielded monospecific 
antisera. 
LDL and VLDL were isolated from plasma by density gradient ultracentrifugation essen- 
tially as described by Chung et al. (29).  Venous blood from a normal donor who had fasted 
overnight was anticoagulated with 0.1% wt/vol Na2 EDTA, and 10 ml of plasma was separated 
immediately. The plasma was adjusted to a  density of 1.30 g/ml, by addition of 4.93 g solid 
KBr per 10 ml plasma, and layered underneath ~26 ml of a solution of NaCI-Na2 EDTA pH 
7.4,  density 1.006  g/ml in a  38.5-ml Beckman  centrifuge tube  (Beckman Instruments,  Inc., 
Spinco Div., Palo Alto, CA). The tube was spun for 2.5 h at 10°C and 50,000 rpm in a Beckman 
VTi-50 vertical tube rotor, and the contents were then fractionated into 1.0-ml vol by upward 
displacement with a  solution of 30%  wt/vol KBr in  20%  wt/vol sucrose. The A2s0 of each 
fraction was measured and they were all assayed for cholesterol and apolipoprotein B (apoB). 
Lipid  Composition.  Triglycerides were  determined  using  the  triglycerides kit  from  Dow 
Diagnostics (Uniscience Ltd., Cambridge, England). Total and free cholesterol were assayed 
using a  modification of the enzymic procedure described by Allan et  al.  (30).  Lipoprotein 
phospholipids were assayed as lipid phosphorus by the modification of the Fiske-Subba-Row 
method described by Marinetti (31). 
Antisera.  Monospecific rabbit anti-human CRP was raised by immunization with isolated 
pure CRP.  The IgG fraction of the antiserum was prepared by affinity chromatography on 
protein A-Sepharose (Pharmacia Ltd.) according to the manufacturer's instructions. Affinity- 
purified anti-CRP antibodies were prepared by passing whole rabbit anti-CRP serum over a 
column of CNBr-activated Sepharose to which pure CRP had been coupled (see below). After 
extensive washing with phosphate-buffered isotonic saline, pH 7.4, containing 10 mM EDTA, 
the column was eluted at 4°C with glycine-HCl buffer at pH 2.2, and the effluent was collected 
into  tubes containing  1.0-ml  vol of 1.0  M  K2HPO4.  The  eluted material was  pure  IgG as 232  LIPOPROTEINS  SELECTIVELY BOUND BY C-REACTIVE PROTEIN 
evidenced by SDS-PAGE of reduced samples. Polyvalent antiserum to NHS was  raised by 
repeated immunization  of sheep.  Rabbit antiserum to human/~-lipoprotein (Miles-Yeda Ltd., 
Rehovoth, Israel),  goat anti-human apoB (Immuno Diagnostika, Vienna, Austria), and sheep 
anti-human  apoA-I (Seward Labs, London) were obtained as indicated. Monospecific  antiserum 
to human serum amyloid P component (SAP)  was prepared by immunization with isolated 
pure SAP (32, 28). 
Immobilized Proteins.  Isolated CRP was coupled to CNBr-activated Sepharose beads (Phar- 
macia Ltd.) according to the manufacturer's instructions. After coupling, the CRP-Sepharose 
was washed extensively with 0.01 M  Tris-buffered 1.14 M  NaC1 pH 8.0 containing 10 mM 
EDTA to remove noncovalently associated material. The recommended alternate washes  at 
pH 4.0 and pH 8.0 were avoided to minimize damage to the coupled CRP. Isolated SAP was 
coupled to  Sepharose as  reported  previously (33). Rabbit IgG anti-CRP preparations were 
coupled to CNBr-activated Sepharose at pH 7.4 in phosphate-buffered saline (0.65 M). The 
whole IgG fraction was coupled at 20 mg/ml of Sepharose,  and immunopurified  IgG anti-CRP 
antibodies were coupled at 5 mg/ml of Sepharose. 
Human Serum.  Fresh NHS was obtained by allowing venous blood from laboratory volunteers 
to clot at room temperature for 2-4 h before centrifugation. All donors were on normal diets 
and were  not  fasted.  In some experiments serum  from  a  single donor was  used,  in others 
different sera  were  pooled.  Acute-phase sera containing raised levels of CRP were obtained 
during routine investigation  of patients with Hodgkin's disease, Crohn's disease, and rheumatoid 
arthritis. 
Protein Assays.  Approximate quantitation of total protein was obtained by measurement of 
A~0, and all samples were also  examined at  320  nm to check for  light scattering. Specific 
proteins were detected and identified by double immunodiffusion  or by immunoelectrophoresis 
in 1% wt/vol agarose gel (Indubiose A37, IBF SA, Clichy, France) in 0.075 M  veronal buffer, 
pH 8.6, containing 0.01 M EDTA. CRP in fractions from density gradient ultracentrifugation 
of acute-phase serum was  detected and quantitated by electroimmunoassay (sensitivity 1-2 
mg/liter; coefficient  of variation of replicate assays  10%) (34) or by a solid-phase immunora- 
diometric assay,  which we have reported elsewhere  (35) (sensitivity 1 /~g/liter; coefficient of 
variation 5-10%).  Isolated pure CRP  was  used to calibrate both these assays.  LDL  in the 
fractions from density gradient ultracentrifugation  or ultracentrifugal flotation and after elution 
from CRP-Sepharose columns was quantitated by electroimmunoassay with anti-apoB serum 
using samples of the starting material as calibration standards. 
PAGE.  Gradient PAGE analysis of native proteins was performed in 4-30% gradient gets 
(Pharmacia Ltd.)  run according to the manufacturer's instructions. Standard globular proteins 
used as markers were: thyroglobulin  669K, ferritin 440K, catalase 232K, lactate dehydrogenase 
140K, and albumin 67K, obtained from Pharmacia Ltd. SDS-PAGE analysis was undertaken 
in slab gels using the method of Laemmli (36). Marker polypeptides were fibronectin 220- 
225K and a2-macroglobulin 181K, and the Pharmacia kit of phosphorylase b  94K, albumin 
67K, ovalbumin 43K, and carbonic anhydrase 30K as  markers.  Lipoprotein samples were 
lyophilized, delipidated with methanol/ether, 1:2 wt/vol, and washed twice with ether before 
solubilization of the apoproteins by boiling in sample buffer. 
Agarose Gel Electrophoresis.  Samples to be tested and control samples of NHS and plasma 
from a patient with type IIB hyperlipoproteinemia  were subjected to agarose gel electrophoresis 
and stained for lipid by standard techniques (37). 
Ultracentrifugation Experiments.  Linear 10-40% wt/wt sucrose  (BDH Chemicals Ltd., Poole, 
England) gradients were  formed by sequential layering of 1.1  ml of sucrose  solutions (40%, 
30%, 20%, 10%) into 5.5-ml  polycarbonate ultracentrifuge tubes (3441t-111; MSE Scientific 
Instruments, Crawley, England). After allowing diffusion for 5 h at 4 °, 200-/xl samples of acute- 
phase serum that had been diluted 1:3 with 0.01 M  Tris-buffered 0.14  M  NaC1 containing 
0.002 M CaCI2 pH 8.0 (Tris-saline-Ca) or with 0.01 M buffered 0.14 M NaCI containing 0.01 
M  EDTA pH 8.0  (Tris-saline-EDTA) were  layered on top of the gradients. Serum samples 
containing -100 mg/liter of CRP from three patients each with Crohn's disease,  rheumatoid 
arthritis, and Hodgkin's disease were tested.  Separate sucrose solutions were made up in Tris- 
saline-Ca and in Tris-saline-EDTA, and each serum sample was run both in calcium and in 
EDTA. Loaded tubes were centrifuged at 40,000 rpm for  16 h at 4 ° using a swing out rotor DE  BEER  ET AL.  233 
(43127-126;  MSE Scientific Instruments) in an MSE Prepspin 65 ultracentrifuge. After ultra° 
centrifugation, 100-/~1 fractions were collected from the bottom of the tube. In each experiment 
the amount of material sedimenting to the bottom of the tube was determined after elution of 
the  pellet with  buffer containing  10  mM  EDTA.  Isolated pure  CRP  was  also  run  under 
identical conditions. 
A sample (1.0 ml with A2a0 =  hl) of the material eluted from CRP-Sepharose with EDTA 
was diluted to 10 ml with NaC1-EDTA, density 1.006 g/ml, and the density adjusted to 1.30 g/ 
ml  by addition of solid KBr.  It was  then  subjected to density gradient ultracentrifugation 
exactly as described above for isolation of LDL from normal plasma (29). 
Gel Filtration Experiments.  Samples (5-ml) of acute-phase sera containing >100 mg/liter of 
CRP were run on a 2.6 ×  100-cm  column of Sephacryl $300 equilibrated with Tris-saline-Ca 
or Tris-saline-EDTA. The column was eluted with the appropriate buffer at 16 ml/h, and 5.0- 
ml fractions were collected and assayed for CRP by electroimmunoassay. Isolated pure CRP 
was also run on the same column both in calcium and in EDTA. 
Affinity Chromatography  Experiments.  The capacity of CRP immobilized on Sepharose to bind 
serum constituents was tested by passing fresh NHS over columns of CRP-Sepharose at 4°C. 
The columns were pre-equilibrated with Tris-saline-Ca and, after passing serum over them, 
were washed with the same buffer until the A~ao of the effluent was zero. Elution with Tris- 
saline-EDTA was then started, and all the eluate with Significant absorbance at 280 nm was 
collected, pooled, and concentrated by uhrafihration on a  PM30  membrane in the Amieon 
Diaflo system  (Amieon Corp., Scientific Sys. Div., Lexington, MA). The capacity of CRP- 
Sepharose to bind isolated LDL was tested in the same protocol, whereas in other experiments, 
elution of material from the serum-treated CRP-Sepharose with heparin  (1  mg/ml in Tris- 
saline-Ca) or phosphorylcholine (Sigma Chemical Co. Ltd., Poole, Dorset, England) (0.001  M 
in Tris-saline-Ca) was attempted. Columns of anti-CRP-Sepharose bearing either the whole 
IgG fraction of anti-CRP serum or the affinity-purified anti-CRP antibodies were saturated 
with isolated pure CRP. They were then washed extensively with Tris°saline-Ca before passage 
of NHS  over them,  followed by further Tris-saline-Ca and  finally elution with Tris-saline- 
EDTA. Controls for the specificity of binding by CRP-Sepharose were provided by columns of 
SAP-Sepharose, bovine serum albumin-Sepharose, normal sheep IgG-Sepharose, and ethanol- 
amine-Sepharose prepared and tested as described previously (33). 
Results 
Form of CRP in Acute-phase Serum.  The CRP  in acute-phase serum was eluted from 
gel filtration columns of Sephacryl $300  in the same fractions regardless of whether 
the column was run  in Tris-saline-Ca or Tris-saline-EDTA. Isolated pure CRP  also 
eluted in precisely the same position. On density gradient uhracentrifugation, CRP 
in acute-phase serum and isolated pure CRP both sedimented to the same position on 
gradients containing calcium orEDTA.  In most cases, no significant amount of CRP 
from acute-phase serum sedimented more rapidly than the main CRP peak, however, 
in one patient with Crohn's disease and extensive abdominal fistulae, trace quantities 
of rapidly sedimenting CRP  were detected, comprising altogether 0.1%  of the total 
CRP  (Fig.  1). In no case were significant amounts of CRP  detected that sedimented 
more slowly than the main peak of CRP,  and there were no fractions in which both 
CRP and LDL were detected (Fig. 2). These results suggest that CRP in acute-phase 
serum exists almost entirely in a  free form, not complexed with any ligand capable of 
altering its apparent molecular size or sedimentation characteristics. 
Calcium-dependent Binding of Serum Proteins by CRP-Sepharose.  Although CRP in acute- 
phase  serum  is  not  apparently  complexed,  the  capacity  of CRP  to  bind  serum 
constituents  was  tested  by  passing  fresh  NHS  over  columns  of  CRP-Sepharose 
prepared by covalent conjugation  of pure CRP  to CNBr-Sepharose.  After washing 
with  Tris-saline-Ca until  no  further  material absorbing at  280  nm  was  eluted,  the 234  LIPOPROTEINS  SELECTIVELY  BOUND  BY  C-REACTIVE  PROTEIN 
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Fla.  1.  Sucrose density gradient ultracentrifugation of serum from two patients with severe active 
Crohn's disease  containing >100 mg/liter of CRP. The distribution of CRP in calcium (--) and 
EDTA-containing (- - -) gradients was identical in all patients tested, as shown on the left, except 
the individual shown on the right in whose serum ~0.1% of the total CRP sedimented ahead of the 
main peak. The arrows indicate the peak fraction of isolated pure CRP run on the same gradients. 
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Fro.  2.  Sucrose  density gradient  ultracentrifugation of serum  from  a  patient  with septicemia 
containing 129 mg/liter of CRP. The distribution of CRP (0) and of LDL (O) in calcium- (--) and 
EDTA-containing (- - -) gradients is shown. 
TABLE  I 
Calcium-dependent Binding of Serum Proteins by CRP-Sepharose 
Quantity of CRP coupled (mg/ml of Sepharose)  0.1  1.0  2.0  5.0 
A~80 of EDTA eluate  0.017  0.037  0.109  0.489 
2-ml vol of NHS were offered to separate 1.0-ml vol of Sepharose bearing the quantities of 
CRP shown. After extensive washing with Tris-saline-Ca each column was eluted with 2 ml 
of Tris-saline-EDTA. 
columns  were  eluted  with  Tris-saline-EDTA.  Significant  amounts  of protein  were 
always  obtained,  provided  there  was  1  mg  or  more  of  CRP  coupled  per  ml  of 
Sepharose  (Table  I)  and  increased sharply as the density of CRP  on the solid phase 
was increased. The eluates did not show any absorbance  or light scattering at 320 nm. 
Passage of >2.0  ml of NHS  over the column  of 1 ml of Sepharose,  bearing  5  mg  of 
CRP,  did  not  yield  increased  amounts  of protein  in the eluate.  The  yields obtained 
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serum albumin-Sepharose,  normal sheep IgG-Sepharose, or ethanolamine-Sepharose, 
the eluates of which contained only traces of protein as we have reported previously 
(33). 
Characterization  by  Gradient  PAGE  of  the  Serum Proteins Bound  by  CRP-Sepharose. 
Analysis in gradient PAGE, without denaturation, of the material eluted with EDTA 
after passing NHS over CRP-Sepharose, always revealed two components, the major 
one comprising ~80% of the total protein (Fig. 3). The minor band, with an apparent 
molecular weight of ~250,000, which was not seen in lightly loaded gels (Fig. 4, track 
3) migrated in the same position as isolated pure SAP. This protein is a normal serum 
constituent  with  a  known calcium-dependent  binding affinity for agarose,  and  it  is 
therefore always obtained when Sepharose exposed to NHS in the presence of calcium 
is eluted with EDTA (32). The other component eluted from CRP-Sepharose, which 
gave a  trail  from the origin leading to a  discrete band corresponding to an apparent 
molecular weight of 2  ×  106 or more  (Fig.  3), was apparently specifically bound by 
the immobilized CRP.  It was never seen in eluates  from any of the control columns 
mentioned  above  (33),  neither  was  it  present  in  the  eluate  from  SAP-Sepharose 
columns (33)  (Fig. 4). 
SAP is closely related  to, though distinct  from, CRP, and they are known to have 
different  calcium-dependent  ligand-binding  specificity  (27).  When  aggregated,  im- 
mobilized  SAP  is  exposed  to NHS,  it  selectively binds  fibronectin  and  C4-binding 
protein  (33), which yield a  quite distinct  pattern  in gradient  PAGE from that  given 
by the material  bound by CRP  (Fig. 4). 
Identification of the Material  Selectively Bound by  CRP-Sepharose as  Lipoprotein.  When 
the proteins eluted from CRP-Sepharose were subjected to electrophoresis in agarose 
gel and then stained with Sudan Black, a  band corresponding in mobility to normal 
plasma fl-lipoprotein  was revealed  (Fig.  5).  Traces of material  with  pre-fl  mobility 
were also present  (Fig. 5).  Immunoelectrophoretic analysis of the eluate using antise- 
rum raised against it demonstrated three components (Fig. 6):  (a) there was a  protein 
Fro. 3.  4-30%  gradient PAGE of undenatured proteins eluted with EDTA after passage of NHS 
over immobilized CRP. Track 1, marker proteins of known molecular weight; track 2, eluate (,'1280 
= 0.28) from CRP immobilized on immunopurified anti-CRP-Sepharose; tracks 3, 4, two separate 
preparations of eluates (Am0  =  1.1 and  1.4, respectively) from CRP-Sepharose bearing 4 mg CRP/ 
ml of Sepharose. 
F1o. 4.  4-30%  gradient PAGE of undenatured  proteins eluted with EDTA after passage of NHS 
over SAP-Sepharose (track 2)  or CRP-Sepharose (track 3).  Track  1, marker proteins of known 
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Fro.  5.  Electrophoresis  in agarose gel of proteins  eluted with EDTA after passage of NHS over 
CRP-Sepharose.  Gel stained for lipid with Sudan Black. Tracks  1, 5, whole  NHS;  tracks  2, 3, 
different eluates from CRP-Sepharose;  track 4, serum from a patient with type IIB hyperlipopro- 
teinemia. 
FIG. 6.  Immunoelectrophoresis  of proteins  eluted with EDTA after passage of NHS over CRP- 
Sepharose. Upper trough, polyvalent anti-NHS serum; lower trough, antiserum raised by immuni- 
zation with the EDTA eluate. The arrow shows the position of a faint arc with pre-/~ mobility. 
Fio.  7.  Immunodiffusion  analysis of proteins eluted with EDTA after passage of NHS over CRP- 
Sepharose. Above, gel stained for lipid with Sudan Black; below, same gel subsequently stained for 
protein with Coomassie Blue.  1, proteins  from NHS eluted from CRP-Sepharose  with EDTA; 2, 
antiserum raised  against  1; 3, antiserum to  1 absorbed with isolated  SAP;  4, anti-/~-lipoprotein 
serum; 5, anti-apo B serum. 
with y-mobility, identifiable by immunodiffusion as IgG, traces of which can always 
be  found  in  eluates  from  any  Sepharose  column;  (b)  there  was  a  protein  with  a- 
mobility, which was identified as SAP  (see below);  and  (c)  there was  an arc with fl- 
mobility which, alone of the three components present, stained with Sudan  Black as 
well  as  with  Coomassie  Blue.  Immunoelectrophoresis  against  a  strong  polyvalent 
sheep anti-human serum gave these same three arcs and also a  weaker one with pre- 
fl mobility (Fig. 6). 
In double immunodiffusion tests,  the antiserum raised against  the serum proteins 
eluted from CRP-Sepharose gave two distinct precipitation lines with the eluate (Fig. 
7). One of these,  which did not stain with Sudan Black, was absent after absorption 
of the antiserum with SAP-Sepharose and therefore was due to SAP in the eluate and 
anti-SAP  in the  antiserum  (Fig.  7).  The  second  precipitation  line stained  strongly 
with Sudan Black, and therefore contained lipid, and also gave a  reaction of complete oz BEER ET AL.  237 
identity with  the  lines  formed between  the eluate and  antisera  to fl-lipoprotein or 
apoB (Fig.  7). These results indicate that the material from serum selectively bound 
in a calcium-dependent fashion by CRP-Sepharose was lipoprotein in nature with fl 
and possibly some pre-fl electrophoretic mobility and contained apoB. 
Characterization  of  the  Material  Selectively  Bound by  CRP-Sepharose  as  LDL  and 
VLDL.  The EDTA eluate from CRP-Sepharose exposed to NHS in the presence of 
calcium  was  analyzed  by  density  gradient  ultracentrifugation.  A  major  peak  of 
material absorbing at 280 nm, containing all the detectable cholesterol, was obtained 
in the same fractions in which LDL was found when normal human plasma was run 
under identical conditions  (Fig. 8). Some absorbance at 280 nm was also present in 
fractions corresponding to the position  of VLDL.  Traces of absorbing material  in 
fractions  corresponding  to  high  density  lipoprotein  (HDL)  probably  represented 
trailing from the origin. 
Analysis by SDS-PAGE of the material bound by CRP-Sepharose revealed three 
protein bands. The major one migrated in the same position as apoB from isolated 
LDL, a  faint band corresponding to apoE from VLDL was seen, and the subunit of 
SAP was also present. There were no bands corresponding to any other apolipopro- 
teins. Also, in double immunodiffusion analysis of the eluted proteins against antise- 
rum to apoA-I, no precipitation lines were seen. The relative amounts ofphospholipid, 
triglyceride, esterified, and nonesterified cholesterol found in the eluate from CRP- 
Sepharose differed slightly from the typical composition of LDL particles, but were 
compatible with the presence of a mixture of LDL with some VLDL (Table II). 
Binding of  Isolated LDL by CRP-Sepharose.  A quantity of isolated LDL corresponding 
to 0.7  ml of normal plasma was passed over CRP-Sepharose  (5  mg CRP on  1 ml 
Sepharose) in the presence of calcium. It all bound to the column and was quantita- 
tively recovered by subsequent elution of the column with EDTA. 
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FxG. 8.  Analysis by density gradient ultracentrifugation of proteins eluted with EDTA after 
passage of NHS over CRP-Sepharose. The horizontal bars mark the fractions in which VLDL, 
LDL, and HDL were located when normal human plasma was run under identical conditions. 
TABLE II 
Lipid Composition of Serum Lipoproteins Bound by CRP-Sepharose 
Relative quantity of lipid  Lipoprotein  bound  by CRP  Typical LDL 
Phospholipid  1  1 
Triglyceride  0.9  0.3 
Total cholesterol  0.9  1.3 
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TABLE III 
Calcium-dependent Binding of Serum Proteins by CRP Immobilized on 
Anti-CRP-Sepharose 
CRP  Vol NHS  A~s0 in 
Anti-CRP coupled  bound  offered  EDTA 
eluate 
mg  ml 
Whole  IgG  fraction  (120  mg on  6  ml  8.4  50  0.18" 
Sepharose) 
Immunopurified anti-CRP antibody (10  7  50  1.45:~ 
mg on 2 ml Sepharose) 
Immunopurified anti-CRP antibody (10  7  5  1.40~ 
mg on 2 ml Sepharose) 
The anti-CRP Sepharose columns shown were saturated with the quantities 
of pure CRP indicated and then exposed to NHS. After extensive washing 
with Tris-saline-Ca, bound protein was eluted with Tris-saline-EDTA. 
* No LDL was detectable in this eluate. 
These eluates  contained  the  same lipoproteins  as  the  eluate  from  CRP- 
Sepharose (Fig. 3). 
Elution by Phospho~ylcholine of Lipoproteins Bound by CRP-Sepharose.  After passing NHS 
over CRP-Sepharose in the presence of calcium, all the bound lipoprotein was eluted 
with 1 mM phosphorylcholine in Tris°saline-Ca. No further lipoprotein was obtained 
by  subsequent  passage  of Tris-saline-EDTA  over  the  column.  In  contrast,  after 
exposing CRP-Sepharose to NHS in calcium, heparin at  1 mg/ml in Tris-saline-Ca 
eluted no lipoprotein at all.  Subsequent  passage of Tris-saline-EDTA led to quanti- 
tative recovery of the LDL. 
Calcium-dependent  Binding  of  Serum  Proteins  by  CRP  Immobilized  on  Anti-CRP- 
Sepharose.  The IgG fraction of rabbit anti-CRP serum was coupled to Sepharose at 
20 mg/ml, and a  6.0-ml column of this material was saturated with 8.4 mg of pure 
isolated  CRP.  However, when  NHS  was passed over this  column  and  the column 
then washed with Tris-saline-Ca, subsequent elution with Tris-saline-EDTA did not 
yield significant amounts of protein  (Table III). In contrast, when  10 mg of immu- 
nopurified anti-CRP antibodies was coupled to 2.0 ml of Sepharose and then saturated 
with a  total of 7.0  mg of CRP, this column was able to bind and yield appreciable 
amounts  of protein  from  NHS.  Analysis  of the  eluate  showed  that  it  contained 
precisely the same proteins as the eluate from CRP immobilized at a sufficient density 
directly on Sepharose (Fig. 3, Table III). The total quantity of protein in the eluate 
from the CRP-anti-CRP-Sepharose column was the same regardless of whether 50 or 
5 ml of NHS was offered (Table III). The total Azs0 of the eluate was 1.4, and because 
the quantity of SAP present was only 60/~g, contributing A2s0 of 0.10, the remainder 
represents the capacity of the 7.0 mg of immobilized CRP to bind lipoproteins. 
Discussion 
Our findings with regard to the size and sedimentation behavior of CRP in acute- 
phase human serum confirm those previously reported  by Kushner and  Somerville 
(26)  for CRP  in  both  human  and  rabbit  serum.  Although  they  used  calcium-free 
phosphate and citrate buffers, the present experiments comparing calcium-containing 
with citrate or EDTA buffers did not reveal significant amounts of complexed CRP. DE BEER ET AL.  239 
Pontet et al. (38) have suggested that CRP in acute-phase rabbit serum exists entirely 
in a high molecular weight form due to complexing with LDL, but like Kushner and 
Somerville (26), we have been unable to reproduce this observation using either gel 
fltration  or  density  gradient  ultracentrifugation  (M.  L.  Baltz  and  M.  B.  Pepys, 
unpublished observations). 
In contrast to the behavior of free CRP in the serum, CRP that had been aggregated 
by immobilization on Sepharose beads acquired a selective binding capacity for LDL 
and  traces of VLDL from whole normal human  serum.  Expression of the binding 
depended upon a sufficient degree of  aggregation of CRP molecules and only occurred 
appreciably when >1  mg of CRP was coupled per ml of Sepharose. Similarly, CRP 
immobilized by uptake onto anti-CRP-Sepharose failed to bind LDL unless immu- 
nopurified anti-CRP antibodies were used to produce the anti-CRP-Sepharose. 
This situation is quite distinct from that observed with immobilized SAP. SAP is 
closely related to CRP in structure, having 60-70% homology of amino acid sequence 
(39, 40), but its calcium-dependent ligand-binding specificity is different (27).  SAP 
immobilized directly on Sepharose or by uptake onto anti-SAP-Sepharose selectively 
binds fibronectin and C4-binding protein from NHS but does not  bind detectable 
amounts of lipoprotein  (33).  SAP-anti-SAP-Sepharose binds  fibronectin more effi- 
ciently than directly coupled SAP-Sepharose, and each pair of SAP molecules taken 
up by a single anti-SAP molecule is capable of reacting with one fibronectin molecule 
(33). In contrast, aggregation or close association of many CRP molecules on the solid 
phase was required to permit expression of the binding reactivity for LDL. In view of 
this fact, the large size of LDL, which partly excludes it from the Sepharose beads, 
and the difficulty in quantitating LDL particles in molar terms, it is not possible to 
calculate the reaction ratio of aggregated CRP and fluid phase LDL. However, from 
the experiments with  CRP  immobilized on immunopurified  anti-CRP  coupled to 
Sepharose, and assuming an LDL particle mass of-2  ×  106, a maximal estimate of 
100 CRP molecules involved in binding 1 LDL particle can be derived. 
LDL that  had  been  bound  by CRP-Sepharose was  completely eluted either by 
chelation of calcium ions or by exposure to free phosphorylcholine, but heparin had 
no effct on the binding. This suggests that the reaction involved primarily the calcium- 
dependent phosphorylcholine-binding site of CRP, although a contribution from the 
cation-binding site cannot be excluded. The basis for the specificity of CRP-Sepharose 
for LDL rather than VLDL, which was  hound only in  trace amounts,  and  HDL, 
which was not bound at all, is not clear. However, it is worth noting that LDL is the 
most cationic lipoprotein and HDL the least. All the lipoproteins contain phospholip- 
ids  and  therefore potential  ligands  for CRP.  The  selective binding  of LDL  may 
depend both on the precise nature and/or accessibility ofphospholipids on the particle 
surface and on the presence, nature, or distribution of accessory ligand sites, particu- 
larly cationic groups.  Perhaps apoB, which is the predominant apoprotein of LDL 
and is also present in VLDL, but not in HDL, may play a part (5). 
Regardless  of their precise molecular mechanism,  the present  observations have 
important physiological and pathophysiological implications. By virtue of its ligand- 
binding properties, CRP can  form complexes in vitro and presumably also in vivo 
with  a  wide variety of materials both of extrinsic and  autogenous origin.  If CRP 
aggregated in such complexes can then selectively bind LDL, there could be significant 
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formed in the circulation that subsequently bind LDL are unlikely to circulate freely 
and would probably be rapidly cleared by the reticuloendothelial system. This may 
explain our failure to find complexed CRP  in acute-phase sera from patients with 
active inflammatory, neoplastic, and infective conditions in which potential ligands 
are released into the circulation. 
Aggregated or complexed human CRP is known to efficiently activate the classical 
complement pathway (41, 42) and such complement activation may also contribute 
to clearance from the circulation. However, neither rabbit nor rat CRP is capable of 
activating its respective autologous complement  (43,  18),  so it  seems  unlikely that 
complement activation is a necessary, integral part of the function of CRP. Also, it is 
noteworthy that CRP-Sepharose selectively bound LDL but not C 1 from fresh NHS, 
in  contrast  to  IgG-Sepharose,  which  bound  C1  very  efficiently  under  identical 
conditions (44). 
CRP binds to damaged cells both in vitro (9) and in vivo (10-12), and it has been 
suggested that by then activating complement, at least in humans, it may contribute 
to the inflammation required for resolution and repair (45). It is not clear what the 
beneficial effects would be of trapping LDL at sites of tissue injury, but a  possible 
harmful effect may be the deposition of LDL in vessel walls after endothelial injury. 
This is a purely speculative concept at present, but is nonetheless susceptible to further 
experimental investigation, which  is currently in  progress. Whatever the  results  of 
these  particular  studies,  the  fact  that  CRP  molecules  that  have  been  aggregated 
acquire a new and selective reactivity for LDL, which they do not express when they 
are free in the serum, seems likely to have biological relevance. 
Summary 
C-reactive protein (CRP), the classical acute-phase protein, can bind phospholipids 
by virtue of its specific, calcium-dependent reactivity with phosphorylcholine residues. 
However, analysis  of acute-phase serum  by gel  filtration and  by density  gradient 
ultracentrifugation showed that  the CRP was in a  free, uncomplexed form, despite 
the  coexistent  presence  of the  various  classes  of serum  lipoproteins,  all  of which 
contain phospholipids. In contrast, when isolated CRP was aggregated by immobili- 
zation at a  sufficient density on a  solid phase and then exposed to normal human 
serum,  it  selectively bound  low  density lipoprotein  (LDL)  and  traces  of very low 
density  lipoprotein.  The  reaction  was  calcium  dependent  and  reversible  by  free 
phosphorylcholine but not by heparin.  LDL isolated from normal plasma was also 
bound by aggregated CRP. 
CRP reacts in vitro with a wide variety of different ligands both of extrinsic and of 
autogenous origin, e.g., microbial products and damaged cell membranes, respectively. 
If CRP  aggregated  in  vivo  by  complexing  with  these  ligands  then  acquires  the 
capacity to selectively bind LDL, the phenomenon may have significant implications 
for the function of CRP and for the metabolism, clearance, and deposition of LDL. 
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